Suraj Estate Developers Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2025 to approve I. Increase in Authorized Capital from existing Rs. 30,00,00,000 (Rupees Thirty Crores) divided into 6,00,00,000 (Six Crores) Equity Shares of Rs. 5/- each to Rs. 34,00,00,000 (Thirty-Four Crores) divided into 6,80,00,000 (Six Crores Eighty Lakhs) Equity Shares of Rs. 5/- each.II. Fund raising by way of issuance of Equity shares or any other equity-linked or convertible securities or warrants, up to ₹ 500 Crores in one or more tranches, through all or any permissible mode or method, including, private placement, preferential issue, rights issue, qualified institution placement (QIP) or such other modes as may be permitted, subject to approval of shareholders of the Company and subject to necessary regulatory/statutory approvals, as may be required.III. Necessary proposals for raising funds and an increase in the authorized share capital have been included in the agenda of the forthcoming 39th Annual General Meeting (AGM) for seeking shareholders' approval. IV. Rescheduling of AGM from September 19, 2025, to September 30, 2025.
SURAJEST · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suraj Estate Developers' board has approved increasing the authorised share capital from Rs. 30 Crores to Rs. 34 Crores (raising equity shares from 6 crore to 6.8 crore of Rs. 5 face value each). The company plans to raise up to Rs. 500 Crores through equity shares or equity-linked instruments such as warrants, convertible securities, via private placement, preferential issue, rights issue, QIP, or other permitted routes, in one or more tranches. These proposals will be placed before shareholders at the 39th AGM. The AGM date has been rescheduled from September 19, 2025 to September 30, 2025.
A potential equity dilution of up to Rs. 500 Crores is on the table, subject to shareholder and regulatory approvals. Near-term stock price may face pressure depending on the pricing and mode of the eventual issue, while the rescheduling of the AGM gives shareholders a little more time to review the proposals.